JP2010527917A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010527917A5 JP2010527917A5 JP2010506715A JP2010506715A JP2010527917A5 JP 2010527917 A5 JP2010527917 A5 JP 2010527917A5 JP 2010506715 A JP2010506715 A JP 2010506715A JP 2010506715 A JP2010506715 A JP 2010506715A JP 2010527917 A5 JP2010527917 A5 JP 2010527917A5
- Authority
- JP
- Japan
- Prior art keywords
- ifnα
- expression profile
- inducible
- patient
- marker expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (23)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92422007P | 2007-05-03 | 2007-05-03 | |
| US92421907P | 2007-05-03 | 2007-05-03 | |
| US60/924,219 | 2007-05-03 | ||
| US60/924,220 | 2007-05-03 | ||
| US92458407P | 2007-05-21 | 2007-05-21 | |
| US60/924,584 | 2007-05-21 | ||
| US96018707P | 2007-09-19 | 2007-09-19 | |
| US60/960,187 | 2007-09-19 | ||
| US99617607P | 2007-11-05 | 2007-11-05 | |
| US99617407P | 2007-11-05 | 2007-11-05 | |
| US60/996,174 | 2007-11-05 | ||
| US60/996,176 | 2007-11-05 | ||
| US99621907P | 2007-11-06 | 2007-11-06 | |
| US60/996,219 | 2007-11-06 | ||
| US99682007P | 2007-12-06 | 2007-12-06 | |
| USPCT/US2007/024947 | 2007-12-06 | ||
| USPCT/US2007/024941 | 2007-12-06 | ||
| PCT/US2007/024941 WO2008070135A2 (en) | 2006-12-06 | 2007-12-06 | Methods of treating systemic lupus erythematosus |
| US60/996,820 | 2007-12-06 | ||
| PCT/US2007/024947 WO2008070137A2 (en) | 2006-12-06 | 2007-12-06 | Interferon alpha-induced pharmacodynamic markers |
| US696308P | 2008-02-08 | 2008-02-08 | |
| US61/006,963 | 2008-02-08 | ||
| PCT/US2008/062646 WO2008137838A2 (en) | 2007-05-03 | 2008-05-05 | Interferon alpha-induced pharmacodynamic markers |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013230753A Division JP2014064577A (ja) | 2007-05-03 | 2013-11-07 | インターフェロンα誘導性薬力学的マーカー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010527917A JP2010527917A (ja) | 2010-08-19 |
| JP2010527917A5 true JP2010527917A5 (enExample) | 2011-06-16 |
| JP5411129B2 JP5411129B2 (ja) | 2014-02-12 |
Family
ID=39944226
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010506715A Expired - Fee Related JP5411129B2 (ja) | 2007-05-03 | 2008-05-05 | インターフェロンα誘導性薬力学的マーカー |
| JP2010506714A Withdrawn JP2010526107A (ja) | 2007-05-03 | 2008-05-05 | 自己免疫疾患の自己抗体マーカー |
| JP2013230753A Pending JP2014064577A (ja) | 2007-05-03 | 2013-11-07 | インターフェロンα誘導性薬力学的マーカー |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010506714A Withdrawn JP2010526107A (ja) | 2007-05-03 | 2008-05-05 | 自己免疫疾患の自己抗体マーカー |
| JP2013230753A Pending JP2014064577A (ja) | 2007-05-03 | 2013-11-07 | インターフェロンα誘導性薬力学的マーカー |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9181345B2 (enExample) |
| EP (2) | EP2076590A4 (enExample) |
| JP (3) | JP5411129B2 (enExample) |
| AU (2) | AU2008247395A1 (enExample) |
| CA (2) | CA2686861A1 (enExample) |
| WO (2) | WO2008137838A2 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201704689XA (en) | 2008-01-18 | 2017-07-28 | Harvard College | Methods of detecting signatures of disease or conditions in bodily fluids |
| SMT201700063T1 (it) * | 2009-09-03 | 2017-03-08 | Medimmune Llc | Diagnosi di interferoni di tipo 1 |
| AU2011223789A1 (en) | 2010-03-01 | 2012-09-20 | Caris Life Sciences Switzerland Holdings Gmbh | Biomarkers for theranostics |
| KR20130043104A (ko) | 2010-04-06 | 2013-04-29 | 카리스 라이프 사이언스 룩셈부르크 홀딩스 | 질병용 순환 생물학적 지표들 |
| MX2013000917A (es) | 2010-07-23 | 2013-07-05 | Harvard College | Metodos para detectar las enfermedades o condiciones usando celulas fagociticas. |
| AU2011280997A1 (en) | 2010-07-23 | 2013-02-28 | President And Fellows Of Harvard College | Methods of detecting autoimmune or immune-related diseases or conditions |
| SG10201505723UA (en) | 2010-07-23 | 2015-09-29 | Harvard College | Methods for detecting signatures of disease or conditions in bodily fluids |
| CA2806304A1 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting prenatal or pregnancy-related diseases or conditions |
| US9244079B2 (en) | 2010-09-22 | 2016-01-26 | National University Corporation Chiba University | Testing method and testing reagent for angiitis |
| GB201017520D0 (en) * | 2010-10-15 | 2010-12-01 | Sense Proteomic Ltd | Biomarkers |
| WO2012149228A1 (en) * | 2011-04-26 | 2012-11-01 | Genentech, Inc. | Compositions and method for treating autoimmune diseases |
| AU2013204880B2 (en) * | 2011-04-26 | 2016-11-24 | Genentech, Inc. | Compositions and method for treating autoimmune diseases |
| EP2923205B1 (en) * | 2012-11-23 | 2019-05-15 | Baerlecken, Niklas | Analysis for adult-onset still's disease |
| EP2931356B1 (en) * | 2012-12-14 | 2019-03-06 | Mindera Corporation | Methods and devices for detection and acquisition of biomarkers |
| NZ771629A (en) | 2013-03-09 | 2022-12-23 | Harry Stylli | Methods of detecting cancer |
| WO2014164362A1 (en) | 2013-03-09 | 2014-10-09 | Harry Stylli | Methods of detecting prostate cancer |
| WO2015085172A2 (en) * | 2013-12-06 | 2015-06-11 | Celgene Corporation | Methods for determining drug efficacy for the treatment of diffuse large b-cell lymphoma, multiple myeloma, and myeloid cancers |
| EP4428251A3 (en) | 2014-09-11 | 2024-12-18 | Immunis.AI, Inc. | Methods of detecting prostate cancer |
| MA45554A (fr) | 2016-07-01 | 2019-05-08 | Resolve Therapeutics Llc | Fusions de binucléase optimisées. |
| CN111315767B (zh) | 2017-08-22 | 2025-03-18 | 萨纳生物有限责任公司 | 可溶性干扰素受体及其用途 |
| US12331320B2 (en) | 2018-10-10 | 2025-06-17 | The Research Foundation For The State University Of New York | Genome edited cancer cell vaccines |
| CA3117102A1 (en) | 2018-10-26 | 2020-04-30 | Janssen Biotech, Inc. | Type i interferon signatures and methods of use |
| CN110747190B (zh) * | 2019-11-27 | 2021-03-09 | 浙江华睿生物技术有限公司 | 一种马来酸水合酶突变体及其应用 |
| CN122122462A (zh) * | 2023-09-22 | 2026-05-29 | 默克专利有限公司 | Tlr抑制剂治疗的生物标志物 |
| WO2026004792A1 (ja) * | 2024-06-24 | 2026-01-02 | キヤノンメディカルダイアグノスティックス株式会社 | 細胞性免疫応答活性を測定する方法及びそのためのキット |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60500864A (ja) | 1983-02-04 | 1985-06-06 | ワドリ、テクナラジズ、インコーパレイティド | 近縁関係にあるが別個のタンパク質間に存在する共通決定基に対して特異的なハイブリド−マ抗体の製造および特性づけ |
| GB8303165D0 (en) | 1983-02-04 | 1983-03-09 | Secher D S | Monoclonal antibody |
| DE3306060A1 (de) | 1983-02-22 | 1984-08-23 | Boehringer Ingelheim International GmbH, 6507 Ingelheim | Neue immunglobulin-produzierende hybridzellinien, deren verwendung und verfahren zu deren herstellung |
| ATE78262T1 (de) | 1985-06-11 | 1992-08-15 | Ciba Geigy Ag | Hybrid-interferone. |
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| FR2692168B1 (fr) | 1992-06-16 | 1995-03-24 | Centre Nat Rech Scient | Préparation et utilisation de nouveaux systèmes colloïdaux dispersibles à base de cyclodextrine, sous forme de nanosphères. |
| US5888511A (en) * | 1993-02-26 | 1999-03-30 | Advanced Biotherapy Concepts, Inc. | Treatment of autoimmune diseases, including AIDS |
| US6077835A (en) | 1994-03-23 | 2000-06-20 | Case Western Reserve University | Delivery of compacted nucleic acid to cells |
| US5972901A (en) | 1994-03-23 | 1999-10-26 | Case Western Reserve University | Serpin enzyme complex receptor--mediated gene transfer |
| CA2186118C (en) | 1994-03-23 | 2010-10-19 | Richard W. Hanson | Compacted nucleic acids and their delivery to cells |
| JP2002506436A (ja) | 1997-06-13 | 2002-02-26 | ザ ジョンズ ホプキンス ユニバーシティー | 治療用ナノスフェア |
| US20050008683A1 (en) * | 2000-06-29 | 2005-01-13 | Becton Dickinson And Company | Method for delivering interferons to the intradermal compartment |
| US20040265874A1 (en) * | 2000-10-17 | 2004-12-30 | Bio-Rad Laboratories, Inc. | Pattern recognition method for diagnosis of systemic autoimmune diseases |
| JP4394350B2 (ja) * | 2001-01-09 | 2010-01-06 | ベイラー リサーチ インスティテュート | 対象における自己免疫疾患の治療法及びｉｎｖｉｔｒｏ診断アッセイ |
| US7087726B2 (en) * | 2001-02-22 | 2006-08-08 | Genentech, Inc. | Anti-interferon-α antibodies |
| AU2002365514A1 (en) * | 2001-11-30 | 2003-06-10 | Innogenetics N.V. | Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma |
| DK1569696T3 (da) * | 2002-11-21 | 2010-11-15 | Bayhill Therapeutics Inc | Fremgangsmåder og immunmodulatoriske nukleinsyrepræparater til forebyggelse og behandling af sygdomme |
| AU2004271200A1 (en) * | 2003-09-05 | 2005-03-17 | Gtc Biotherapeutics, Inc. | Method for the production of fusion proteins in transgenic mammal milk |
| PT2418220T (pt) * | 2003-12-10 | 2017-10-04 | Squibb & Sons Llc | Anticorpos contra interferão alfa e suas utilizações |
| EP1851248B1 (en) * | 2005-02-10 | 2016-08-10 | Baylor Research Institute | Anti-interferon alpha monoclonal antibodies and methods for use |
| US20070117105A1 (en) * | 2005-05-12 | 2007-05-24 | Crow Mary K | Interferon assay |
| US20070065844A1 (en) * | 2005-06-08 | 2007-03-22 | Massachusetts Institute Of Technology | Solution-based methods for RNA expression profiling |
| ES2432026T3 (es) * | 2005-08-05 | 2013-11-29 | Genentech, Inc. | Métodos y composiciones para detectar trastornos autoinmunes |
| US7608395B2 (en) * | 2005-09-15 | 2009-10-27 | Baylor Research Institute | Systemic lupus erythematosus diagnostic assay |
| KR20080074120A (ko) * | 2005-10-13 | 2008-08-12 | 휴먼 게놈 사이언시즈, 인코포레이티드 | 자가항체 양성 질환 환자의 치료에 유용한 방법 및 조성물 |
| WO2008070135A2 (en) * | 2006-12-06 | 2008-06-12 | Medimmune, Llc. | Methods of treating systemic lupus erythematosus |
| US20110287022A1 (en) * | 2008-06-20 | 2011-11-24 | Medlmmune, Llc | Interferon alpha-induced pharmacodynamic markers |
| SMT201700063T1 (it) * | 2009-09-03 | 2017-03-08 | Medimmune Llc | Diagnosi di interferoni di tipo 1 |
-
2008
- 2008-05-05 WO PCT/US2008/062646 patent/WO2008137838A2/en not_active Ceased
- 2008-05-05 EP EP08769294A patent/EP2076590A4/en not_active Withdrawn
- 2008-05-05 CA CA002686861A patent/CA2686861A1/en not_active Abandoned
- 2008-05-05 CA CA002685147A patent/CA2685147A1/en not_active Abandoned
- 2008-05-05 WO PCT/US2008/062639 patent/WO2008137835A2/en not_active Ceased
- 2008-05-05 AU AU2008247395A patent/AU2008247395A1/en not_active Abandoned
- 2008-05-05 EP EP08747639A patent/EP2068924A4/en not_active Withdrawn
- 2008-05-05 JP JP2010506715A patent/JP5411129B2/ja not_active Expired - Fee Related
- 2008-05-05 JP JP2010506714A patent/JP2010526107A/ja not_active Withdrawn
- 2008-05-05 AU AU2008247398A patent/AU2008247398B2/en not_active Ceased
-
2011
- 2011-11-07 US US13/290,850 patent/US9181345B2/en active Active
-
2013
- 2013-11-07 JP JP2013230753A patent/JP2014064577A/ja active Pending
-
2014
- 2014-09-23 US US14/494,439 patent/US20150132313A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010512315A5 (enExample) | ||
| Powell et al. | Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response | |
| Sypabekova et al. | Electrochemical aptasensor using optimized surface chemistry for the detection of Mycobacterium tuberculosis secreted protein MPT64 in human serum | |
| Chen et al. | Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis | |
| Camela et al. | Towards personalized medicine in psoriasis: current progress | |
| Conti et al. | Biomarkers to personalize the treatment of rheumatoid arthritis: focus on autoantibodies and pharmacogenetics | |
| An et al. | From moderately severe to severe hypertriglyceridemia induced acute pancreatitis: circulating miRNAs play role as potential biomarkers | |
| MX2014004712A (es) | Metodos para mejorar el diagnostico de enfermedad inflamatoria intestinal. | |
| RU2010144502A (ru) | Композиции и способы для лечения и диагностики астмы | |
| NZ590988A (en) | Biomarkers for anti-tnf treatment in ulcerative colitis and related disorders | |
| Qasem et al. | Genetic polymorphisms in tumour necrosis factor receptors (TNFRSF1A/1B) illustrate differential treatment response to TNFα inhibitors in patients with Crohn’s disease | |
| Flanagan et al. | The Candida albicans TOR-activating GTPases Gtr1 and Rhb1 coregulate starvation responses and biofilm formation | |
| Hao et al. | Multi-omics in allergic rhinitis: mechanism dissection and precision medicine | |
| JP2013178260A5 (enExample) | ||
| Glatt et al. | Elongator: transcriptional or translational regulator? | |
| WO2007124309A3 (en) | Methods for detecting mutations in jak2 nucleic acid | |
| Liu et al. | Functional effect of polymorphisms in the promoter of TNFAIP3 (A20) in acute pancreatitis in the Han Chinese population | |
| Sun et al. | Downregulation of microRNA‐101‐3p participates in systemic lupus erythematosus progression via negatively regulating HDAC9 | |
| Yue et al. | Association of interleukin-18 gene polymorphisms with the outcomes of hepatitis C virus infection in high-risk Chinese Han population | |
| Safarinejad | Analysis of association between the 5‐HTTLPR and STin2 polymorphisms in the serotonin‐transporter gene and clinical response to a selective serotonin reuptake inhibitor (sertraline) in patients with premature ejaculation | |
| JP2015502137A5 (enExample) | ||
| Cruz et al. | Pyroptosis in ulcerative colitis: biomarkers and therapeutic targets | |
| CN103820545B (zh) | 用于检测人abcg2基因突变的探针、引物及试剂盒 | |
| Moraes Holst et al. | Downregulated mucosal autophagy, alpha kinase-1 and IL-17 signaling pathways in active and quiescent ulcerative colitis | |
| Patrick et al. | Large-scale functional inference for skin-expressing lncRNAs using expression and sequence information |